Search

Author/Creator Komanduri, Krishna V

1. Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. Issue 6 (June 2019)

Authors:
Wilky, Breelyn A; Trucco, Matteo M; Subhawong, Ty K; Florou, Vaia; Park, Wungki; Kwon, Deukwoo; Wieder, Eric D; Kolonias, Despina; Rosenberg, Andrew E; Kerr, Darcy A; Sfakianaki, Efrosyni; Foley, Mark; Merchan, Jaime R; Komanduri, Krishna V; Trent, Jonathan C
Journal:
Lancet oncology
Issue:
Volume 20:Issue 6(2019)
Page Start:
837
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. Issue 2 (16th December 2020)

Authors:
Maus, Marcela V; Alexander, Sara; Bishop, Michael R; Brudno, Jennifer N; Callahan, Colleen; Davila, Marco L; Diamonte, Claudia; Dietrich, Jorg; Fitzgerald, Julie C; Frigault, Matthew J; Fry, Terry J; Holter-Chakrabarty, Jennifer L; Komanduri, Krishna V; Lee, Daniel W; Locke, Frederick L; Maude, S...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search